These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32269269)

  • 1. De novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls.
    Gellrich D; Eder K; Högerle C; Becker S; Canis M; Gröger M
    Sci Rep; 2020 Apr; 10(1):6048. PubMed ID: 32269269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular allergen IgE tests show neosensitizaions occurring during house dust mite specific immunotherapy].
    Long Z; Zhang Q; Zou Z; Zheng Y; Chen J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Jul; 38(7):572-577. PubMed ID: 38973033
    [No Abstract]   [Full Text] [Related]  

  • 3. Salivary Immunoglobulin A, E, and G4 Levels Specific to Dermatophagoides pteronyssinus in Allergic Rhinitis Patients Treated With Subcutaneous Immunotherapy.
    Liu Y; Xing Z; Wang J; Geng C
    Am J Rhinol Allergy; 2018 Nov; 32(6):458-464. PubMed ID: 30124065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Effect of Sublingual and Subcutaneous Immunotherapy in Dust Mite-Allergic Children With Asthma/Rhinitis: A 3-Year Prospective Randomized Controlled Trial.
    Karakoc-Aydiner E; Eifan AO; Baris S; Gunay E; Akturk E; Akkoc T; Bahceciler NN; Barlan IB
    J Investig Allergol Clin Immunol; 2015; 25(5):334-42. PubMed ID: 26727762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
    Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
    Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Immunoreactive Levels of IgG4 Correlate with Clinical Responses during the Maintenance Phase of House Dust Mite Immunotherapy.
    Feng M; Su Q; Lai X; Xian M; Shi X; Wurtzen PA; Qin R; Zeng X; Li J
    J Immunol; 2018 Jun; 200(12):3897-3904. PubMed ID: 29728509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
    Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
    Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
    Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy.
    Rodríguez-Domínguez A; Berings M; Rohrbach A; Huang HJ; Curin M; Gevaert P; Matricardi PM; Valenta R; Vrtala S
    J Allergy Clin Immunol; 2020 Nov; 146(5):1097-1108. PubMed ID: 32298697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the effect of early subcutaneous specific immunotherapy on the levels of dust mite allergen-specific antibodies and polyunsaturated fatty acid metabolism].
    Li SY; Zheng PY; Zhai YY; Zhang YD; Gan H; Huang HM; Luo WT; Jiang MY; Zhang GZ; Zhong RF; Cheng ZK; Sun SX; Sun BQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jun; 58(6):778-790. PubMed ID: 38955724
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
    Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
    Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy.
    Chen J; Zhou Y; Wang Y; Zheng Y; Lai X; Westermann-Clark E; Cho SH; Kong W
    Am J Rhinol Allergy; 2017 May; 31(3):156-160. PubMed ID: 28490399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients.
    Soyyigit S; Guloglu D; Ikinciogullari A; Secil D; Oztuna D; Mungan D; Misirligil Z; Sin BA
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):244-251.e2. PubMed ID: 26945497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-specific IgE and allergen immunotherapy in allergic children.
    Tosca M; Silvestri M; Accogli A; Rossi GA; Ciprandi G
    Immunotherapy; 2014; 6(1):29-33. PubMed ID: 24341881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.